Citations

Clear

4847 citation(s) found for "Tu, Eric".

Response to: Functional neuroimaging and diagnostic reasoning
Durning, Steven J. , Artino, Anthony R. , Costanzo, Michelle E. , Beckman, Thomas J. , Vleuten, Cees van der , Roy, Michael J. , Holmboe, Eric S. , Schuwirth, Lambert

Mayo Clinic

Medical Teacher | April 7, 2016 | Volume: 38 | Issue: 7 | Pages: 753-754

10.3109/0142159x.2016.1150991 | PMID 27049880 Get It

Vertebral Artery Injury in Cervical Spine Surgery: Results from AOSpine North America Multicenter Study on 16,582 Patients
Kannan, Abhishek , Mai, Harry, Hsu, Wellington K. , Hilibrand, Alan S. , Traynelis, Vincent C. , Gokaslan, Ziya L. , Mroz, Thomas E. , Bydon, Mohamad , Smith, Zachary A. , Massicotte, Eric M. , Mai, Harry, Nassr, Ahmad , Arnold, Paul M. , Fehlings, Michael G. , Riew, Kiehyun Daniel

Mayo Clinic

Global Spine Journal | April 4, 2016 | Volume: 6 | Issue: 1_suppl | Pages: s-0036-1582986-s-0036-1582986

10.1055/s-0036-1582986 Get It

Introduction Vertebral artery injury is a rare but serious complication of cervical spine surgery with an overall incidence rate of 1.4% (Rampersaud, 2006). Iatrogenic injury of the vertebral artery can lead to serious complications including lateral medullary (Wallenberg) syndrome, quadriparesis, and mortality. The high rate of vertebral artery anomalies in the general population mandates assessment via advanced imaging modalities in the preoperative period (Schroeder, 2013). The rarity of this complication makes it difficult to set expectations after an injury is encountered. This study utilized a multi-center database to compile outcomes data after vertebral artery injury during a cervical spine procedure. Materials and Methods A multi-center retrospective case series was compiled involving 23 medical institutions. Inclusion criteria included patients who underwent cervical spine surgery between 2005–2011 and who sustained a vertebral artery injury. IRBs were obtained from all institutions and data was sent to a private research organization that collected and collated all of the data. Patients were evaluated on the basis of condition-specific functional status using the Neck Disability Index (NDI), modified Japanese Orthopaedic Association (mJOA) score, the Nurick scale, and the 36-Item Short-Form Health Survey (SF-36). Results Vertebral artery injuries were identified in a total of 14 of 16,582 total patients screened (8.4 per 10,000). The mean age of patients with vertebral artery injury was 59 years (+/− 10) with a female predominance (78.6%). Diagnoses of affected patients included 7 with myelopathy, 3 with radiculopathy, 1 with cervical instability, and 2 with metastatic disease. The mean duration of operative time for cases was 4.7 hours (+/− 1.8). Vertebral artery injury was also associated with substantial blood loss (770 mL), although only 3 cases required transfusion. Of the 14 cases, 7 occurred with an anterior only approach, 3 cases with posterior only approach, and 4 during circumferential approach. Average length of hospital stay for these patients was 10 days (+/− 8). Notably, 13 of the 14 (92.86%) cases reportedly resolved without residual deficits. Compared with preoperative baseline NDI, Nurick, and SF-36 physical and mental component scores for these patients, there were no observed changes after surgery ( p = 0.20 Ð 0.94). Conclusion Vertebral artery injuries are potentially catastrophic complications that can be sustained from either anterior or posterior cervical spine approaches. This adverse event is associated with an increase in hospital stay and functional disability measured on NDI score. However, the data from this study suggests that with proper steps to ensure hemostasis, patients recover function at a high rate and do not exhibit residual deficits (13 out of 14). Preoperative imaging studies may provide insight into VA anomalies and anatomic variations and are vital to the preoperative assessment. Furthermore, although surgeons should expect increased blood loss once a vertebral artery injury is encountered, patients do not often require a blood transfusion.
Prognostic Factors for Survival in Surgical Series of Symptomatic Metastatic Epidural Spinal Cord Compression: A Prospective North American Multi-Centre Study in 142 Patients
Nater, Anick , Tetreault, Lindsay , Kopjar, Branko , Dekutoski, Mark B. , Finkelstein, Joel , Fisher, Charles G. , France, John C., Gokaslan, Ziya L. , Rhines, Laurence D. , Rose, Peter S. , Schuster, James M. , Sahgal, Arjun , Massicotte, Eric M. , Fehlings, Michael G. , Arnold, Paul M. , Vaccaro, Alexander R.

Mayo Clinic

Global Spine Journal | April 4, 2016 | Volume: 6 | Issue: 1_suppl | Pages: s-0036-1582881-s-0036-1582881

10.1055/s-0036-1582881 Get It

Introduction Symptomatic Metastatic Epidural Spinal Cord Compression (MESCC) afflicts up to 10% of all cancer patients and is associated with shortened survival and worsened quality of life. This study aims to identify the key survival prognostic factors in MESCC patients who were surgically treated for a single symptomatic lesion. Material and Methods 142 MESCC patients were enrolled in a prospective North American multi-center study and followed postoperatively for 12 months. Using univariate analyses, Kaplan-Meier methods, and log-rank tests the prognostic value of various clinical predictors were assessed. Non-collinear predictors with p < 0.05 in univariate analyses were included in the final Cox proportional hazards model. Results The overall median survival was 7.7 months (range: 3 days – 35.6 months); breast cancer had the longest median survival (12.1 months). Ten patients (7%), whose primary cancer were lung (3), kidney (3), sarcoma (2), prostate (1), and breast (1), died within 30-days postoperatively and 88 had died at 12 months (62%). Univariate analyses yielded eight significant predictors for survival: the growth of primary tumor (Tomita Grade 1 vs Grade 2 and 3), BMI, gender, preoperative SF-36 physical component, EQ-5D, and ODI scores as well as the presence of either visceral or extraspinal bony metastasis. The multiple regression analysis revealed that the Tomita grade (Grade 1 vs Grade 2 and 3; HR: 2.81, p = 0.007), the absence of visceral metastasis (HR: 2.01; p = 0.0044), and higher score on SF-36 physical component (HR: 0.95, p < 0.0001) were independent predictors for longer survival regardless of the selection method used (backward, forward, or stepwise). Conclusion Slow growing tumor (Tomita Grade 1), absence of visceral metastasis, and lower degree of preoperative physical disability, as reflected by a higher score on the SF-36 physical component questionnaire, are good prognostic factors for survival in selected patients who underwent surgical treatment for a focal symptomatic MESCC lesion.
Survival and Clinical Outcomes in Patients with Metastatic Epidural Spinal Cord Compression: Results from the AOSpine Prospective Multi-Centre Study of 142 patients
Nater, Anick , Tetreault, Lindsay , Kopjar, Branko , Dekutoski, Mark B. , Finkelstein, Joel , Fisher, Charles G. , France, John C., Gokaslan, Ziya L. , Rhines, Laurence D. , Rose, Peter S. , Massicotte, Eric M. , Sahgal, Arjun , Schuster, James M. , Fehlings, Michael G. , Arnold, Paul M. , Vaccaro, Alexander R.

Mayo Clinic

Global Spine Journal | April 4, 2016 | Volume: 6 | Issue: 1_suppl | Pages: s-0036-1582880-s-0036-1582880

10.1055/s-0036-1582880 Get It

Introduction Although surgery is being increasingly used in patients with Metastatic Epidural Spinal Cord Compression (MESCC) as a complementary strategy to radiation and chemotherapy, the impact of surgery on quality of life (QoL) is not well established. This study aimed to prospectively evaluate survival, neurological, functional, and QoL outcomes in MESCC patients undergoing operative management. Material and Methods A total of 142 surgically treated patients with a single symptomatic MESCC lesion enrolled in a prospective North American multi-center study were followed for 12 months. Clinical data, such as Brief Pain Inventory (BPI), ASIA, SF-36, Oswestry Disability Index (ODI), and EQ-5D scores, were obtained both pre- and post-operatively. Results The median survival was 7.7 months. The 30-day and 12-month mortality rates were 9% and 62%, respectively. Six weeks post-operatively, ambulatory status ( p = 0.02) and bladder control ( p = 0.03) were significantly improved. Overall, 67.5% of ASIA B, C, or D patients gained at least 1 grade after surgery, 25% remained stable, and 7.5% deteriorated. ODI, EQ-5D, BPI scores were significantly improved at each follow-up (p ≤ 0.01). SF-36 scores were generally higher after surgery for mental and physical components, and for all domains except energy/fatigue. The incidence of wound complications was 10% and 2 patients required a second surgery (screw malposition and epidural hematoma). Conclusion Surgical intervention, as a complementary adjunct to radiation and chemotherapy, provides immediate and sustained improvement in pain, neurological, functional, and QoL outcomes with acceptable risks in patients with a focal symptomatic MESCC lesion.
Validity and feasibility of the EMG direct observation tool (EMG-DOT)
Rubin, Devon I., Laughlin, Ruple S. , Sorenson, Eric J. , Watson, James C. , Jones, Lyell K. , Juul, Dorthea, Park, Yoon Soo , Leep Hunderfund, Andrea N, Hunderfund, Andrea N. Leep , Park, Yoon Soo , Jones, Lyell K

Mayo Clinic

Neurology | March 31, 2016 | Volume: 86 | Issue: 17 | Pages: 1627-1634

10.1212/wnl.0000000000002609 | PMID 27029634 Get It

Vascular Toxicities of Cancer Therapies
Herrmann, Joerg , Yang, Eric H. , Iliescu, Cezar , Charitakis, Konstantinos, Hakeem, Abdul , Toutouzas, Konstantinos , Leesar, Massoud A. , Marmagkiolis, Konstantinos , Iliescu, Cezar A, Cilingiroglu, Mehmet , Grines, Cindy L. , Çilingiroğlu, Mehmet , Yang, Eric

Mayo Clinic

Circulation | March 28, 2016 | Volume: 133 | Issue: 13 | Pages: 1272-1289

10.1161/circulationaha.115.018347 | PMID 27022039 Get It

Since the late 1990s, there has been a steady decline in cancer-related mortality, in part related to the introduction of so-called targeted therapies. Intended to interfere with a specific molecular pathway, these therapies have, paradoxically, led to a number of effects off their intended cancer tissue or molecular targets. The latest examples are tyrosine kinase inhibitors targeting the Philadelphia Chromosome mutation product, which have been associated with progressive atherosclerosis and acute vascular events. In addition, agents designed to interfere with the vascular growth factor signaling pathway have vascular side effects ranging from hypertension to arterial events and cardiomyocyte toxicity. Interestingly, the risk of cardiotoxicity with drugs such as trastuzumab is predicted by preexisting cardiovascular risk factors and disease, posing the question of a vascular component to the pathophysiology. The effect on the coronary circulation has been the leading explanation for the cardiotoxicity of 5-fluorouracil and may be the underlying the mechanism of presentation of apical ballooning syndrome with various chemotherapeutic agents. Classical chemotherapeutic agents such as cisplatin, often used in combination with bleomycin and vinca alkaloids, can lead to vascular events including acute coronary thrombosis and may be associated with an increased long-term cardiovascular risk. This review is intended to provide an update on the evolving spectrum of vascular toxicities with cancer therapeutics, particularly as they pertain to clinical practice, and to the conceptualization of cardiovascular diseases, as well. Vascular toxicity with cancer therapy: the old and the new, an evolving avenue.
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network
Lee, Seonjoo , Viqar, Fawad, Zimmerman, Molly E. , Narkhede, Atul, Benzinger, Tammie L.S. , Marcus, Daniel S. , Fagan, Anne M. , Goate, Alison , Fox, Nick C. , Cairns, Nigel J., Buckles, Virginia, Martins, Ralph N. , Saykin, Andrew J. , Masters, Colin L. , Ringman, John M. , Ryan, Natalie S. , Förster, Stefan , Laske, Christoph , Schofield, Peter R. , Salloway, Stephen , Correia, Stephen , Jack, Clifford R. , Weiner, Michael W. , Bateman, Randall J. , Morris, John C. , Mayeux, Richard , Network, for the Dominantly Inherited Alzheimer, Tosto, Giuseppe , Holtzman, David M. , Ghetti, Bernardino , McDade, Eric , Sperling, Reisa Anne , Brickman, Adam M. , Network, for the Dominantly Inherited Alzheimer, Jack, Clifford R , Saykin, Andrew J , Schofield, Peter R , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Fox, Nick C , Morris, John C , Goate, Alison M

Mayo Clinic

Annals of Neurology | March 26, 2016 | Volume: 79 | Issue: 6 | Pages: 929-939

10.1002/ana.24647 | PMID 27016429 Get It

ObjectiveWhite matter hyperintensities (WMHs) are areas of increased signal on T2‐weighted magnetic resonance imaging (MRI) scans that most commonly reflect small vessel cerebrovascular disease. Increased WMH volume is associated with risk and progression of Alzheimer's disease (AD). These observations are typically interpreted as evidence that vascular abnormalities play an additive, independent role contributing to symptom presentation, but not core features of AD. We examined the severity and distribution of WMH in presymptomatic PSEN1, PSEN2, and APP mutation carriers to determine the extent to which WMH manifest in individuals genetically determined to develop AD.MethodsThe study comprised participants (n = 299; age = 39.03 ± 10.13) from the Dominantly Inherited Alzheimer Network, including 184 (61.5%) with a mutation that results in AD and 115 (38.5%) first‐degree relatives who were noncarrier controls. We calculated the estimated years from expected symptom onset (EYO) by subtracting the affected parent's symptom onset age from the participant's age. Baseline MRI data were analyzed for total and regional WMH. Mixed‐effects piece‐wise linear regression was used to examine WMH differences between carriers and noncarriers with respect to EYO.ResultsMutation carriers had greater total WMH volumes, which appeared to increase approximately 6 years before expected symptom onset. Effects were most prominent for the parietal and occipital lobe, which showed divergent effects as early as 22 years before estimated onset.InterpretationAutosomal‐dominant AD is associated with increased WMH well before expected symptom onset. The findings suggest the possibility that WMHs are a core feature of AD, a potential therapeutic target, and a factor that should be integrated into pathogenic models of the disease. Ann Neurol 2016;79:929–939
Rheumatology Workforce Planning in Western Countries: A Systematic Literature Review
Dejaco, Christian , Lackner, Angelika , Buttgereit, Frank , Matteson, Eric L. , Narath, Markus, Sprenger, Martin , Dejaco, Christian , Buttgereit, Frank

Mayo Clinic

Arthritis Care & Research | March 25, 2016 | Volume: 68 | Issue: 12 | Pages: 1874-1882

10.1002/acr.22894 | PMID 27015436 Get It

ObjectiveTo compare health care planning models forecasting rheumatology workforce requirements in western countries.MethodsA systematic literature review was conducted through medical databases (Ovid MEDLINE, Embase, CINAHL, and Cochrane Library) and the grey literature. All articles reporting a rheumatology workforce model were included.ResultsThe search yielded 6,508 articles, and 14 publications (on 12 studies) were included. Workforce models were available for the US (n = 3), Canada (n = 3), the US plus Canada (n = 1), Germany (n = 2), Spain (n = 1), and the UK (n = 2). The number of rheumatologists required to serve a population of 100,000 people was calculated, with a range of 0.7 (UK, calculated for 1988) to 3.5 (Spain, calculated for 2021). Most models used a needs‐based approach (n = 6); 3 studies each applied a supply‐ or demand‐based method. The following variables were considered by ≥1 model: disease prevalence, patients' referral to rheumatologists, clinical visits/patient/year, population development, factors influencing performance of rheumatologists, patient flow/care sharing, and medical technologies/infrastructure development.ConclusionHeterogeneity in methods used, the period or calendar years for which the estimates were projected, and heterogeneity of variables evaluated led to disparate estimates, with results ranging from 0.7 to 3.5 rheumatologists per 100,000 population. An international initiative is needed to agree upon a common approach for a reliable estimation of manpower requirements in rheumatology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population‐Based Cohort Study
Singh, Abha G., Crowson, Cynthia S. , Singh, Siddharth , Denis, Mark, Davis, P, Kremers, Hilal Maradit , Matteson, Eric L. , Chowdhary, Vaidehi , Maradit-Kremers, Hilal, Chowdhary, Vaidehi R, Maradit Kremers, Hilal

Mayo Clinic

Arthritis Care & Research | March 25, 2016 | Volume: 68 | Issue: 11 | Pages: 1664-1670

10.1002/acr.22892 | PMID 27015109 Get It

ObjectiveIt is unclear whether isolated cutaneous lupus erythematosus (CLE) affects cardiovascular risk. We estimated the cumulative incidence and mortality of cardiovascular diseases in a population‐based CLE cohort and compared the risk with a matched non‐CLE cohort.MethodsAll incident cases of CLE in Olmsted County, Minnesota, between 1965 and 2005 were followed until December 2013. The cumulative incidence of cerebrovascular accidents (CVAs [including stroke and transient ischemic attack]), ischemic heart disease (IHD [including coronary artery disease, myocardial infarction, and angina pectoris]), heart failure, and peripheral arterial disease (PAD) was derived and compared to an age‐, sex‐, and calendar year–matched non‐CLE cohort using Cox models.ResultsThere were 155 patients with CLE (mean ± SD age at diagnosis 48 ± 16 years, 65% female, mean ± SD BMI 26.3 ± 7.1 kg/m2, 40% smokers, 9% with diabetes mellitus). During a median followup of 14.6 years, 41 CLE patients had cardiovascular events (15 patients with CVAs, 32 patients with IHD), with a 20‐year cumulative incidence of 31.6%. As compared to non‐CLE subjects, the risk of CVAs (smoking‐adjusted hazard ratio [HR] 2.97 [95% confidence interval (95% CI) 1.13–7.78]) and PAD (HR 2.06 [95% CI 0.99–4.32]) was increased in patients with CLE, but the risk of IHD was not increased (HR 0.94 [95% CI 0.57–1.54]). There was no increase in cardiovascular mortality (HR 1.68 [95% CI 0.76–3.75]). The magnitude of risk for any cardiovascular outcome was not significantly influenced by the extent of cutaneous involvement.ConclusionCLE may be associated with an increased risk of CVAs and PAD, but not IHD. Factors contributing to increased CVA risk in patients with CLE merit evaluation.